--- title: "Pulsenmore (PLSM) stock listing, news and investor profile" url: "https://aibio.space/companies/pulsenmore/" publisher: "aibio.space (Biotech Investor Relations News)" summary: "Pulsenmore Ltd. (NASDAQ: PLSM), United States. Listing facts, related biotech companies and news on aibio.space." --- PLSM Pulsenmore Ltd. NASDAQ · United States # Pulsenmore (PLSM) news Pulsenmore Ltd. is a public biotech or pharmaceutical company listed on NASDAQ under the ticker PLSM, recorded under United States. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them. ## Latest Pulsenmore news We have not published a story on Pulsenmore yet. When there is news, it will appear here. ## Pulsenmore at a glance - **Ticker**: PLSM - **Listing**: NASDAQ - **Country**: United States - **Cash, Dec 31, 2025**: $6.8 million ### Related companies - [Schrodinger](https://aibio.space/companies/schrodinger/) NASDAQ: SDGR - [Medpace Holdings](https://aibio.space/companies/medpace/) NASDAQ: MEDP - [Bio Essence](https://aibio.space/companies/bio-essence/) OTC: BIOE - [Precipio](https://aibio.space/companies/precipio/) NASDAQ: PRPO - [Fortrea Holdings](https://aibio.space/companies/fortrea/) NASDAQ: FTRE - [REVVITY, INC.](https://aibio.space/companies/revvity/) NYSE: RVTY - [BIO-TECHNE](https://aibio.space/companies/bio-techne/) NASDAQ: TECH - [UFP TECHNOLOGIES INC](https://aibio.space/companies/ufp-technologies/) NASDAQ: UFPT ### Also on NASDAQ - [Tango Therapeutics](https://aibio.space/companies/tango-therapeutics/) TNGX - [Gilead Sciences](https://aibio.space/companies/gilead-sciences/) GILD - [COOPER COMPANIES, INC.](https://aibio.space/companies/cooper-companies/) COO - [Clearmind Medicine](https://aibio.space/companies/clearmind-medicine/) CMND - [ProKidney](https://aibio.space/companies/prokidney/) PROK - [Jupiter Neurosciences](https://aibio.space/companies/jupiter-neurosciences/) JUNS ## Pulsenmore annual financials | Line | FY2025 | |---|---| | Revenue | [$12.5 million](https://www.sec.gov/Archives/edgar/data/2064764/000149315226013485/) | | Research and development | [$5.4 million](https://www.sec.gov/Archives/edgar/data/2064764/000149315226013485/) | | Net income (loss) | [-$5.0 million](https://www.sec.gov/Archives/edgar/data/2064764/000149315226013485/) | | Cash from operations | [-$10.3 million](https://www.sec.gov/Archives/edgar/data/2064764/000149315226013485/) | | Cash and equivalents | [$6.8 million](https://www.sec.gov/Archives/edgar/data/2064764/000149315226013485/) | Latest balance sheet, Dec 31, 2025 (20-F): cash and equivalents $6.8 million. Figures as reported to the SEC in XBRL; each one links to its filing. Not adjusted, not investment advice. ## Questions about Pulsenmore What is the ticker symbol of Pulsenmore? Pulsenmore Ltd. trades under the ticker PLSM on NASDAQ. Where is Pulsenmore listed? Pulsenmore Ltd. is listed on NASDAQ. Which country or territory is Pulsenmore listed under? Our directory records Pulsenmore Ltd. under United States. Does aibio.space cover Pulsenmore? aibio.space lists Pulsenmore Ltd. among 2,820 public biotech companies and publishes its news here as stories appear. What was Pulsenmore's revenue last year? $12.5 million for the fiscal year ended Dec 31, 2025, as reported to the SEC. Is Pulsenmore profitable? Pulsenmore Ltd. reported a net loss of $5.0 million for the fiscal year ended Dec 31, 2025, and used $10.3 million of cash in operations, per its annual report to the SEC. How much does Pulsenmore spend on research and development? $5.4 million in the fiscal year ended Dec 31, 2025, per its annual report. How much cash does Pulsenmore have? $6.8 million in cash at Dec 31, 2025, per its 20-F. ## Investor discussion: Pulsenmore Members talk about Pulsenmore (PLSM). Reader posts, not aibio.space reporting, and not investment advice. Rules 1. **Securities violations are strictly forbidden.** No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information. 2. **Say whether you hold the stock.** Every post states long, short or no position. 3. **No paid or sponsored posts.** Do not post for anyone who pays or rewards you. 4. **No buy or sell calls and no price targets.** 5. **No accusations of crime or fraud against named people** unless you link a court filing or a regulator's release that makes them. 6. **No personal details and no spam.** No links at all for your first 7 days as a member. Posts that break the rules may be deleted without notice, and the account restricted or closed. See the [terms](https://aibio.space/terms/#discussion) and the [privacy policy](https://aibio.space/privacy/#discussion). ## Capital-markets timeline Financings, listing notices, splits, legal actions and other investor events at Pulsenmore, newest first. Each line links the filing it comes from. 1. 2026-06-25 Financings Reported a financing. SEC Form 6-K. [Source](https://www.sec.gov/Archives/edgar/data/2064764/000149315226030145/ex99-1.htm) ## Stock chart Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. [Open NASDAQ:PLSM on TradingView](https://www.tradingview.com/symbols/NASDAQ-PLSM/). ## Listing details Pulsenmore Ltd. is a public biotech or pharmaceutical company listed on NASDAQ under the ticker PLSM, recorded under United States. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them. - **Company**: Pulsenmore Ltd. - **Ticker**: PLSM - **Listing**: NASDAQ - **Country or territory**: United States Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. [Tell us about a change](https://aibio.space/reputation/#update). Work at this company? [Claim this page](https://aibio.space/claim/). Published and maintained by aibio.space. Not investment advice. [How we work](https://aibio.space/disclosures/). Who manages this page **This page is managed by aibio.space.** The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. [How we work](https://aibio.space/disclosures/#paid) · [Terms](https://aibio.space/terms/#news) · [Request a correction](https://aibio.space/reputation/#update) --- Source page: https://aibio.space/companies/pulsenmore/. Facts in aibio.space stories are checked against company filings and releases; opinion is labelled. Cite as: aibio.space, "Pulsenmore (PLSM) stock listing, news and investor profile", 2026-10-31, https://aibio.space/companies/pulsenmore/